WM’s years of detailed testing and optimization has enabled its System to include all Unbanked Persons and all Cash Payments in all countries worldwide into the 21st Century Digital Economy. Solves entrance issues for two of the world’s largest single market-sectors A TUV for 11 000 Kenyan Shillings – equivalent
Innovation Summit World Tour 2021 Image Innovation Summit World Tour 2021 urges rapid acceleration of carbon emission reduction to reach 2050 net zero ambition Expansion of consulting services for meaningful sustainability progress Call to act 3-5 times faster and halve emissions this decade, with smart, green electricity and next-generation automation
How the Workforce Learns report shows diverse learning experiences, manager support and opportunities to stretch skills are core components of employee engagement PLEASANTON, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — A positive learning culture is directly linked to greater organizational agility, faster revenue growth, and increased employee engagement. These are
Certified Investment Management Analyst® -CIMA® certification recognized as global standard for fund allocators Denver, Co, Oct. 12, 2021 (GLOBE NEWSWIRE) — Two associations for investment practitioners who are committed to competent and ethical practice of investment management analysis and fund allocation have formed a multi-year strategic alliance to raise the
Philadelphia, Pennsylvania, Oct. 12, 2021 (GLOBE NEWSWIRE) — FreedomPay, a global leader in Next Level Commerce™ has selected Hill+Knowlton Strategies (H+K) as its communications partner, following a competitive agency review. H+K will work with FreedomPay’s in-house marketing team to execute the global fintech leader’s national communications strategy as it continues its
Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR Lugano, Switzerland – Shanghai, China, October 12, 2021 – Helsinn Group (“Helsinn”), a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer